The beneficial effects of glucagon-like peptide 1-receptor agonists (GLP-1RA) in reducing oxidative stress may be based in part on inhibition of NOX2 in inflammatory monocytes of hypertensive mice, which trigger endothelial dysfunction.98 Here, GLP1R is linked to endothelial dysfunction.